China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for their work on COVID-19 vaccines, smaller and lesser-known companies are also playing…
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…
The latest from Chinese pharma, including a new deal between AstraZeneca and…
One of the largest domestic pharma companies in China (ranking number one from…
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
The latest news from Middle East & North African pharma, including…
A roundup of the latest from the Middle East & Africa region, including…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
The latest from Italian pharma, including the government’s decision to make…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
This article forms part of Healthcare & Life Sciences Review: Switzerland…
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
Although Switzerland is ahead of many of its competitors in Europe on levels of…
The full list of medicines recommended for approval by the European Medicines…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating…
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Singapore is home to a wide range of biopharmaceutical company headquarters,…
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
As the most important pharma hub in its region, and one of the most important…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
The AAM’s Dan Leonard highlights the savings impact that generic and…
Following on from our profile on five of the most promising clinical-stage…
With Rare Disease Day coming up on February 28th, one of the leading…